Build status - In Progress
Search filters

Filters
Clear All

Phase

  • 183
  • 152
  • 2
  • 191
  • 1
  • 148
  • 17
  • 390
  • 1223
  • 588
  • 29
  • 46
  • 3
  • 1151
  • 1223
  • 6

Found 1229 All Conditions trials

A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

100 years or below
All genders
Individuals included in the study will be divided into 2 groups, Stabilization and Control groups, by block randomization method. A standard treatment program (Education + home exercises) will be applied to both groups. In addition to the stabilization group, cervical stabilization exercises will be applied. Individuals will be evaluated with …
99 years or below
All genders
verification email study 2
10 years - 99 years
Male
Phase 1
verification email study 2
10 years - 8 years
All genders
verification email study 2
99 years or below
All genders
verification email study 2
99 years or below
All genders
verification email study 2
99 years or below
All genders
See protocol section 2 See protocol section 2 See protocol section 2
 A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML)
18 years or above
All genders
Phase 1
Interventional
This is a first-in-human, multicenter, open-label, phase 1 study to evaluate the safety, PK, PD and preliminary efficacy of STX-0712 in patients with advanced CMML and AML for whom there are no further treatment options known to confer clinical benefit.
99 years or below
All genders
This study investigates a treatment for adults with acute myeloid leukemia (AML) and multiple myeloma (MM).The purpose of this study is to evaluate the effects of an investigational treatment on these conditions.Who can participate: Adults aged 18 and older diagnosed with acute myeloid leukemia or multiple myeloma may be eligible. …
18 years or above
All genders
Phase 1/2
Interventional
The primary objectives of this study are: (Phase 1b) to investigate the safety and tolerability and to determine the recommended Phase 2 dose (RP2D) for magrolimab in combination with cetuximab; and (Phase 2) to evaluate overall response rate (ORR) of magrolimab in combination with cetuximab in participants with Kirsten rat …
1111 - 1120 of 1229